GLSI Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc. (GLSI) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: July 29, 2026 , by Patel Snehal .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Patel Snehal | CEO and CFO | Buy | 700 | $13.10 | $9.2K | 5,611,402 | |
| Patel Snehal | CEO and CFO | Buy | 1,500 | $13.59 | $20.4K | 5,610,702 | |
| Patel Snehal | CEO and CFO | Buy | 1,500 | $13.62 | $20.4K | 5,609,202 | |
| Patel Snehal | CEO and CFO | Buy | 1,100 | $12.88 | $14.2K | 5,607,702 | |
| Patel Snehal | CEO and CFO | Buy | 2,500 | $13.14 | $32.9K | 5,606,602 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.